div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imagea href=https:reader042fdocumentsusreader042viewer20220314225c72e26609d3f2ad198c1be7html5page1jpg target=_blank img data-url=documentpowerpoint-patients-treated-with-folfoxiri-plus-ras-and-braf-wild-type-folfoxirihtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: PowerPoint Presentation · Patients Treated with FOLFOXIRI plus RAS and BRAF wild-type FOLFOXIRI plus bevacizumab RAS and BRAE RAS FOLFOXIRI RAS BRAE BRAE mutant FOLFIRI plus bevacizumab loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentsusreader042viewer20220314225c72e26609d3f2ad198c1be7html5thumbnails1jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imagea href=https:reader042fdocumentsusreader042viewer20220314225c72e26609d3f2ad198c1be7html5page2jpg target=_blank img data-url=documentpowerpoint-patients-treated-with-folfoxiri-plus-ras-and-braf-wild-type-folfoxirihtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: PowerPoint Presentation · Patients Treated with FOLFOXIRI plus RAS and BRAF wild-type FOLFOXIRI plus bevacizumab RAS and BRAE RAS FOLFOXIRI RAS BRAE BRAE mutant FOLFIRI plus bevacizumab loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentsusreader042viewer20220314225c72e26609d3f2ad198c1be7html5thumbnails2jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imagea href=https:reader042fdocumentsusreader042viewer20220314225c72e26609d3f2ad198c1be7html5page3jpg target=_blank img data-url=documentpowerpoint-patients-treated-with-folfoxiri-plus-ras-and-braf-wild-type-folfoxirihtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: PowerPoint...